Catalent
CTLT
#1585
Rank
A$16.33 B
Marketcap
$89.99
Share price
-0.18%
Change (1 day)
19.72%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of June 2024 : A$0.43 B

According to Catalent's latest financial reports the company has A$0.43 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30A$0.42 B-46%
2022-06-30A$0.77 B-39.66%
2021-06-30A$1.28 B-6.76%
2020-06-30A$1.38 B181.15%
2019-06-30A$0.49 B-11.23%
2018-06-30A$0.55 B38.62%
2017-06-30A$0.39 B114.14%
2016-06-30A$0.18 B-4.86%
2015-06-30A$0.19 B148.51%
2014-06-30A$78.94 M-32.18%
2013-06-30A$0.11 B-14.22%
2012-06-30A$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.52 B 20.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.25 B-40.32%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.97 B 585.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$0.48 B 11.67%๐Ÿ‡บ๐Ÿ‡ธ USA